Rank | Gene Set | Z-score |
---|---|---|
1 | central nervous system myelination (GO:0022010) | 7.62764745 |
2 | axon ensheathment in central nervous system (GO:0032291) | 7.62764745 |
3 | myelination (GO:0042552) | 5.00272168 |
4 | ensheathment of neurons (GO:0007272) | 4.97129351 |
5 | axon ensheathment (GO:0008366) | 4.97129351 |
6 | fatty acid elongation (GO:0030497) | 4.90123393 |
7 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.47102154 |
8 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.37900796 |
9 | negative regulation of neurotransmitter transport (GO:0051589) | 4.37715144 |
10 | detection of molecule of bacterial origin (GO:0032490) | 4.22888330 |
11 | presynaptic membrane assembly (GO:0097105) | 4.16258553 |
12 | negative regulation of cell killing (GO:0031342) | 4.16059723 |
13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.16059723 |
14 | presynaptic membrane organization (GO:0097090) | 4.14395689 |
15 | L-amino acid import (GO:0043092) | 4.06882296 |
16 | neuron cell-cell adhesion (GO:0007158) | 4.01251277 |
17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.97725388 |
18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.96888760 |
19 | neuronal action potential propagation (GO:0019227) | 3.96268872 |
20 | macrophage activation involved in immune response (GO:0002281) | 3.89230718 |
21 | transmission of nerve impulse (GO:0019226) | 3.82910649 |
22 | synaptic vesicle maturation (GO:0016188) | 3.81638368 |
23 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.72587786 |
24 | dendritic spine morphogenesis (GO:0060997) | 3.72000374 |
25 | renal system development (GO:0072001) | 3.70759411 |
26 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.68876402 |
27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.64829623 |
28 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.63247379 |
29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.62807727 |
30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.60740030 |
31 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.59484189 |
32 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.56888206 |
33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.56888206 |
34 | modulation by symbiont of host immune response (GO:0052553) | 3.56888206 |
35 | positive regulation by symbiont of host defense response (GO:0052509) | 3.56888206 |
36 | modulation by symbiont of host defense response (GO:0052031) | 3.56888206 |
37 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.56888206 |
38 | locomotory exploration behavior (GO:0035641) | 3.56593970 |
39 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.53557439 |
40 | glycerophospholipid catabolic process (GO:0046475) | 3.51826775 |
41 | microglial cell activation (GO:0001774) | 3.43350755 |
42 | establishment of mitochondrion localization (GO:0051654) | 3.40755155 |
43 | apical protein localization (GO:0045176) | 3.39712893 |
44 | synaptic vesicle exocytosis (GO:0016079) | 3.37449088 |
45 | detection of other organism (GO:0098543) | 3.36388967 |
46 | regulation of beta-amyloid formation (GO:1902003) | 3.36326146 |
47 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.35329636 |
48 | negative regulation of protein localization to cell surface (GO:2000009) | 3.35071118 |
49 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.34996271 |
50 | macrophage activation (GO:0042116) | 3.34327473 |
51 | adult walking behavior (GO:0007628) | 3.33266393 |
52 | regulation of collateral sprouting (GO:0048670) | 3.32767046 |
53 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.32059156 |
54 | detection of external biotic stimulus (GO:0098581) | 3.31217137 |
55 | regulation of ARF protein signal transduction (GO:0032012) | 3.30322573 |
56 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.30319967 |
57 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.29867496 |
58 | vocalization behavior (GO:0071625) | 3.29541120 |
59 | nerve growth factor signaling pathway (GO:0038180) | 3.29380531 |
60 | myelin maintenance (GO:0043217) | 3.27672766 |
61 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.27283253 |
62 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.27274856 |
63 | protein localization to synapse (GO:0035418) | 3.25650531 |
64 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.25625195 |
65 | glutamate receptor signaling pathway (GO:0007215) | 3.23182794 |
66 | neuron recognition (GO:0008038) | 3.22930159 |
67 | neuronal ion channel clustering (GO:0045161) | 3.22209832 |
68 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.21002876 |
69 | oligodendrocyte differentiation (GO:0048709) | 3.20669421 |
70 | cellular extravasation (GO:0045123) | 3.20174052 |
71 | glutamate secretion (GO:0014047) | 3.16485814 |
72 | neuron-neuron synaptic transmission (GO:0007270) | 3.14439918 |
73 | synaptic transmission, glutamatergic (GO:0035249) | 3.13498287 |
74 | asymmetric protein localization (GO:0008105) | 3.09799271 |
75 | neutrophil activation involved in immune response (GO:0002283) | 3.07468896 |
76 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.06465791 |
77 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.04642905 |
78 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.04517475 |
79 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.03733822 |
80 | negative regulation of axonogenesis (GO:0050771) | 2.99195002 |
81 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.99045710 |
82 | cerebellar granule cell differentiation (GO:0021707) | 2.98201245 |
83 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.96521040 |
84 | amino acid import (GO:0043090) | 2.96444332 |
85 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.95355862 |
86 | signal complex assembly (GO:0007172) | 2.95328294 |
87 | positive regulation of membrane potential (GO:0045838) | 2.94747161 |
88 | regulation of dendritic spine development (GO:0060998) | 2.94677749 |
89 | cholesterol biosynthetic process (GO:0006695) | 2.93876493 |
90 | gamma-aminobutyric acid transport (GO:0015812) | 2.93252285 |
91 | response to peptidoglycan (GO:0032494) | 2.93231161 |
92 | positive regulation of Rap GTPase activity (GO:0032854) | 2.92572872 |
93 | response to methylmercury (GO:0051597) | 2.92415516 |
94 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.92259221 |
95 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.91661979 |
96 | substantia nigra development (GO:0021762) | 2.90069182 |
97 | astrocyte development (GO:0014002) | 2.87595471 |
98 | axonal fasciculation (GO:0007413) | 2.86855581 |
99 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.85296401 |
100 | neutrophil mediated immunity (GO:0002446) | 2.84326624 |
101 | negative regulation of interleukin-12 production (GO:0032695) | 2.83713374 |
102 | cyclic nucleotide catabolic process (GO:0009214) | 2.83165677 |
103 | regulation of glutamate secretion (GO:0014048) | 2.82824508 |
104 | cellular response to epinephrine stimulus (GO:0071872) | 2.82288473 |
105 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.80079270 |
106 | mating behavior (GO:0007617) | 2.79810878 |
107 | detection of biotic stimulus (GO:0009595) | 2.79073658 |
108 | dendritic spine organization (GO:0097061) | 2.78989576 |
109 | exploration behavior (GO:0035640) | 2.78020934 |
110 | negative regulation of interleukin-17 production (GO:0032700) | 2.77315871 |
111 | cellular potassium ion homeostasis (GO:0030007) | 2.76733738 |
112 | long-term synaptic potentiation (GO:0060291) | 2.75980003 |
113 | regulation of synapse structural plasticity (GO:0051823) | 2.75699433 |
114 | regulation of gamma-delta T cell activation (GO:0046643) | 2.75540398 |
115 | eye photoreceptor cell differentiation (GO:0001754) | 2.75379893 |
116 | photoreceptor cell differentiation (GO:0046530) | 2.75379893 |
117 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.75079901 |
118 | negative regulation of synaptic transmission (GO:0050805) | 2.74869786 |
119 | regulation of synaptic vesicle transport (GO:1902803) | 2.74470636 |
120 | regulation of synaptic plasticity (GO:0048167) | 2.74140517 |
121 | dendrite morphogenesis (GO:0048813) | 2.73854177 |
122 | neutrophil activation (GO:0042119) | 2.72976044 |
123 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.72889660 |
124 | detection of bacterium (GO:0016045) | 2.71866628 |
125 | regulation of postsynaptic membrane potential (GO:0060078) | 2.71831251 |
126 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.71075475 |
127 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.70783209 |
128 | long-term memory (GO:0007616) | 2.70619832 |
129 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.66919167 |
130 | regulation of dopamine metabolic process (GO:0042053) | 2.66894357 |
131 | regulation of catecholamine metabolic process (GO:0042069) | 2.66894357 |
132 | neuron remodeling (GO:0016322) | 2.66146517 |
133 | auditory behavior (GO:0031223) | 2.65752302 |
134 | regulation of regulated secretory pathway (GO:1903305) | 2.65750296 |
135 | membrane assembly (GO:0071709) | 2.65134553 |
136 | positive T cell selection (GO:0043368) | 2.64734921 |
137 | response to interleukin-15 (GO:0070672) | 2.64152631 |
138 | negative regulation of T cell mediated immunity (GO:0002710) | 2.64098475 |
139 | import into cell (GO:0098657) | 2.63776546 |
140 | regulation of cellular amide metabolic process (GO:0034248) | 2.63767025 |
141 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.63546412 |
142 | positive regulation of macrophage cytokine production (GO:0060907) | 2.63350877 |
143 | glycine transport (GO:0015816) | 2.63263818 |
144 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.62526720 |
145 | sterol biosynthetic process (GO:0016126) | 2.62196424 |
146 | positive regulation of dendritic spine development (GO:0060999) | 2.61226485 |
147 | negative regulation of amino acid transport (GO:0051956) | 2.60754962 |
148 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.60686426 |
149 | myeloid leukocyte mediated immunity (GO:0002444) | 2.60593833 |
150 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.60413090 |
151 | Golgi to endosome transport (GO:0006895) | 2.60047851 |
152 | sodium ion export (GO:0071436) | 2.59352751 |
153 | behavioral response to cocaine (GO:0048148) | 2.58324529 |
154 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.57807091 |
155 | layer formation in cerebral cortex (GO:0021819) | 2.57460501 |
156 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.57456200 |
157 | regulation of Rap GTPase activity (GO:0032317) | 2.57207045 |
158 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.56945523 |
159 | response to host immune response (GO:0052572) | 2.56945523 |
160 | synaptic transmission, dopaminergic (GO:0001963) | 2.56695673 |
161 | neurotransmitter secretion (GO:0007269) | 2.54666340 |
162 | myeloid cell activation involved in immune response (GO:0002275) | 2.54455747 |
163 | cellular response to ethanol (GO:0071361) | 2.54334762 |
164 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.53533609 |
165 | granulocyte activation (GO:0036230) | 2.50927384 |
166 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.50285213 |
167 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.49631421 |
168 | regulation of leukocyte degranulation (GO:0043300) | 2.48245972 |
169 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.48159611 |
170 | B cell receptor signaling pathway (GO:0050853) | 2.47699169 |
171 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.47501141 |
172 | positive regulation of mast cell activation (GO:0033005) | 2.47117979 |
173 | regulation of macrophage cytokine production (GO:0010935) | 2.46871520 |
174 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.45914164 |
175 | response to muramyl dipeptide (GO:0032495) | 2.45816816 |
176 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.40984070 |
177 | leukocyte aggregation (GO:0070486) | 2.39121415 |
178 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.38388742 |
179 | negative regulation of B cell mediated immunity (GO:0002713) | 2.38388742 |
180 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.36608275 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.98288029 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.84941587 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.83700004 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.79076560 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.76204178 |
6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76167046 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.72641454 |
8 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.64935690 |
9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.41675981 |
10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.41675981 |
11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.38045739 |
12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.34025521 |
13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.33015155 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.30274877 |
15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29377055 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.27848451 |
17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.27348972 |
18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21084819 |
19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.19834687 |
20 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.18459366 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15295837 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.15284542 |
23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.14127704 |
24 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.13193139 |
25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.12693265 |
26 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.09043860 |
27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07303349 |
28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.06043644 |
29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05274288 |
30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04583971 |
31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02612485 |
32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.96365623 |
33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94975859 |
34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.92921714 |
35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85945471 |
36 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.78291076 |
37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.78228575 |
38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.76570908 |
39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.76192258 |
40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75921491 |
41 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71825372 |
42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.71061379 |
43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68047780 |
44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64832569 |
45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.63268684 |
46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.60415804 |
47 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.57854529 |
48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.56993026 |
49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54252227 |
50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53766616 |
51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52169009 |
52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50577323 |
53 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47869336 |
54 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46712072 |
55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.44741203 |
56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44235554 |
57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.43738786 |
58 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.43106136 |
59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41323316 |
60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40613159 |
61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.40482017 |
62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.38923264 |
63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38201275 |
64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.35637312 |
65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35336753 |
66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34648829 |
67 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34496460 |
68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33701154 |
69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.31083655 |
70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30812523 |
71 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30454430 |
72 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29908312 |
73 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29560914 |
74 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27065766 |
75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24757257 |
76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.24352151 |
77 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.22722547 |
78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21549395 |
79 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19706406 |
80 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19133458 |
81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18367665 |
82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16994348 |
83 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.16543921 |
84 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15768210 |
85 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15614480 |
86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.15544477 |
87 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15348769 |
88 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14975523 |
89 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13394494 |
90 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.12968625 |
91 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12877011 |
92 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12369327 |
93 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11884628 |
94 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10406194 |
95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10340892 |
96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.09923566 |
97 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09610134 |
98 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.09518820 |
99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09315162 |
100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.08770306 |
101 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.08560632 |
102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08103726 |
103 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.07017602 |
104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06485143 |
105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04798767 |
106 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04439265 |
107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04439265 |
108 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04436752 |
109 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.04172128 |
110 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00984393 |
111 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00811896 |
112 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99723332 |
113 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99153406 |
114 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98450640 |
115 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98188987 |
116 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98187786 |
117 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97601180 |
118 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97452206 |
119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97211178 |
120 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95723914 |
121 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95590923 |
122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95581138 |
123 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94587042 |
124 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94473501 |
125 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94400858 |
126 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.94375462 |
127 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.94345926 |
128 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94210618 |
129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93321611 |
130 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.92107954 |
131 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91892190 |
132 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91571482 |
133 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91513098 |
134 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90639246 |
135 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90020286 |
136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89602044 |
137 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89367626 |
138 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89307242 |
139 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89089411 |
140 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88668814 |
141 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.88244342 |
142 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88121865 |
143 | * AR_19668381_ChIP-Seq_PC3_Human | 0.88029209 |
144 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.87952297 |
145 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87594452 |
146 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87538413 |
147 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87036088 |
148 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86857027 |
149 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86646506 |
150 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86470521 |
151 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86140074 |
152 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85418622 |
153 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84777448 |
154 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83808747 |
155 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.82762345 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.25049832 |
2 | MP0003880_abnormal_central_pattern | 5.05424248 |
3 | MP0004270_analgesia | 4.06466440 |
4 | MP0003724_increased_susceptibility_to | 3.79578938 |
5 | MP0000920_abnormal_myelination | 3.75950728 |
6 | MP0003635_abnormal_synaptic_transmissio | 3.36094168 |
7 | MP0003303_peritoneal_inflammation | 3.34750450 |
8 | MP0009745_abnormal_behavioral_response | 3.02666845 |
9 | MP0002064_seizures | 3.02556082 |
10 | MP0002822_catalepsy | 2.89377633 |
11 | MP0001486_abnormal_startle_reflex | 2.86995096 |
12 | MP0002272_abnormal_nervous_system | 2.85121434 |
13 | MP0003329_amyloid_beta_deposits | 2.77069713 |
14 | MP0002063_abnormal_learning/memory/cond | 2.73023504 |
15 | MP0003690_abnormal_glial_cell | 2.51753952 |
16 | MP0009046_muscle_twitch | 2.50419273 |
17 | MP0001529_abnormal_vocalization | 2.50099677 |
18 | MP0002572_abnormal_emotion/affect_behav | 2.36148083 |
19 | MP0004885_abnormal_endolymph | 2.32665662 |
20 | MP0005423_abnormal_somatic_nervous | 2.29135614 |
21 | MP0003436_decreased_susceptibility_to | 2.22853305 |
22 | MP0002734_abnormal_mechanical_nocicepti | 2.21045375 |
23 | MP0000778_abnormal_nervous_system | 2.19520575 |
24 | MP0001905_abnormal_dopamine_level | 2.14207353 |
25 | MP0003172_abnormal_lysosome_physiology | 2.11832719 |
26 | MP0002419_abnormal_innate_immunity | 2.08819845 |
27 | MP0004947_skin_inflammation | 2.05129061 |
28 | MP0000569_abnormal_digit_pigmentation | 2.01444702 |
29 | MP0006082_CNS_inflammation | 2.00934809 |
30 | MP0004742_abnormal_vestibular_system | 1.98007717 |
31 | MP0001440_abnormal_grooming_behavior | 1.97556998 |
32 | MP0001968_abnormal_touch/_nociception | 1.97488060 |
33 | MP0008877_abnormal_DNA_methylation | 1.97444022 |
34 | MP0005409_darkened_coat_color | 1.84711285 |
35 | MP0001835_abnormal_antigen_presentation | 1.81802664 |
36 | MP0001501_abnormal_sleep_pattern | 1.77457886 |
37 | MP0003634_abnormal_glial_cell | 1.77087989 |
38 | MP0004142_abnormal_muscle_tone | 1.76767809 |
39 | MP0003828_pulmonary_edema | 1.73846901 |
40 | MP0003191_abnormal_cellular_cholesterol | 1.72653462 |
41 | MP0005386_behavior/neurological_phenoty | 1.69571872 |
42 | MP0004924_abnormal_behavior | 1.69571872 |
43 | MP0001485_abnormal_pinna_reflex | 1.66637486 |
44 | MP0005000_abnormal_immune_tolerance | 1.65807366 |
45 | MP0003183_abnormal_peptide_metabolism | 1.64120227 |
46 | MP0005025_abnormal_response_to | 1.63191160 |
47 | MP0009785_altered_susceptibility_to | 1.63165508 |
48 | MP0001970_abnormal_pain_threshold | 1.61720065 |
49 | MP0002067_abnormal_sensory_capabilities | 1.61121348 |
50 | MP0009780_abnormal_chondrocyte_physiolo | 1.60796514 |
51 | MP0001800_abnormal_humoral_immune | 1.57638293 |
52 | MP0002396_abnormal_hematopoietic_system | 1.57067721 |
53 | MP0005171_absent_coat_pigmentation | 1.57052376 |
54 | MP0003632_abnormal_nervous_system | 1.56655643 |
55 | MP0000955_abnormal_spinal_cord | 1.56608029 |
56 | MP0003300_gastrointestinal_ulcer | 1.56571741 |
57 | MP0002736_abnormal_nociception_after | 1.55565580 |
58 | MP0008569_lethality_at_weaning | 1.54568540 |
59 | MP0002229_neurodegeneration | 1.52975640 |
60 | MP0002733_abnormal_thermal_nociception | 1.52346788 |
61 | MP0003950_abnormal_plasma_membrane | 1.51302428 |
62 | MP0002735_abnormal_chemical_nociception | 1.51231700 |
63 | MP0002723_abnormal_immune_serum | 1.47993716 |
64 | MP0003631_nervous_system_phenotype | 1.46813565 |
65 | MP0002882_abnormal_neuron_morphology | 1.46452656 |
66 | MP0002420_abnormal_adaptive_immunity | 1.45960270 |
67 | MP0000604_amyloidosis | 1.45791653 |
68 | MP0002066_abnormal_motor_capabilities/c | 1.45141560 |
69 | MP0003633_abnormal_nervous_system | 1.43747268 |
70 | MP0001819_abnormal_immune_cell | 1.43092551 |
71 | MP0005671_abnormal_response_to | 1.42527320 |
72 | MP0001790_abnormal_immune_system | 1.41435981 |
73 | MP0005387_immune_system_phenotype | 1.41435981 |
74 | MP0002452_abnormal_antigen_presenting | 1.39956844 |
75 | MP0001986_abnormal_taste_sensitivity | 1.36802674 |
76 | MP0000465_gastrointestinal_hemorrhage | 1.34652952 |
77 | MP0005166_decreased_susceptibility_to | 1.28508216 |
78 | MP0004811_abnormal_neuron_physiology | 1.22283172 |
79 | MP0010678_abnormal_skin_adnexa | 1.22269452 |
80 | MP0005248_abnormal_Harderian_gland | 1.22105196 |
81 | MP0000685_abnormal_immune_system | 1.21962638 |
82 | MP0003045_fibrosis | 1.21346087 |
83 | MP0002557_abnormal_social/conspecific_i | 1.19254980 |
84 | MP0002184_abnormal_innervation | 1.19209794 |
85 | MP0001533_abnormal_skeleton_physiology | 1.18071782 |
86 | MP0003136_yellow_coat_color | 1.18013730 |
87 | MP0004484_altered_response_of | 1.17512082 |
88 | MP0002148_abnormal_hypersensitivity_rea | 1.17366633 |
89 | MP0005167_abnormal_blood-brain_barrier | 1.16702992 |
90 | MP0005551_abnormal_eye_electrophysiolog | 1.16520898 |
91 | MP0000566_synostosis | 1.15812850 |
92 | MP0004883_abnormal_blood_vessel | 1.15149939 |
93 | MP0003763_abnormal_thymus_physiology | 1.13777055 |
94 | MP0005310_abnormal_salivary_gland | 1.13617461 |
95 | MP0005410_abnormal_fertilization | 1.10664526 |
96 | MP0001177_atelectasis | 1.09076863 |
97 | MP0001963_abnormal_hearing_physiology | 1.09007196 |
98 | MP0005646_abnormal_pituitary_gland | 1.07870048 |
99 | MP0003448_altered_tumor_morphology | 1.05917308 |
100 | MP0010234_abnormal_vibrissa_follicle | 1.05276906 |
101 | MP0004130_abnormal_muscle_cell | 1.04948949 |
102 | MP0005164_abnormal_response_to | 1.03817157 |
103 | MP0005464_abnormal_platelet_physiology | 1.03399073 |
104 | MP0002152_abnormal_brain_morphology | 1.03066371 |
105 | MP0001845_abnormal_inflammatory_respons | 1.02952261 |
106 | MP0001851_eye_inflammation | 1.00849715 |
107 | MP0002405_respiratory_system_inflammati | 0.98626652 |
108 | MP0004043_abnormal_pH_regulation | 0.97702217 |
109 | MP0005397_hematopoietic_system_phenotyp | 0.97117664 |
110 | MP0001545_abnormal_hematopoietic_system | 0.97117664 |
111 | MP0000716_abnormal_immune_system | 0.96835138 |
112 | MP0005388_respiratory_system_phenotype | 0.94474622 |
113 | MP0002133_abnormal_respiratory_system | 0.94474622 |
114 | MP0002998_abnormal_bone_remodeling | 0.94043627 |
115 | MP0003656_abnormal_erythrocyte_physiolo | 0.93641589 |
116 | MP0002752_abnormal_somatic_nervous | 0.93627750 |
117 | MP0008004_abnormal_stomach_pH | 0.93127107 |
118 | MP0003075_altered_response_to | 0.92161229 |
119 | MP0004510_myositis | 0.91320678 |
120 | MP0001502_abnormal_circadian_rhythm | 0.90111781 |
121 | MP0008874_decreased_physiological_sensi | 0.89984875 |
122 | MP0001984_abnormal_olfaction | 0.87326611 |
123 | MP0006276_abnormal_autonomic_nervous | 0.87254588 |
124 | MP0002398_abnormal_bone_marrow | 0.86805073 |
125 | MP0005623_abnormal_meninges_morphology | 0.85968239 |
126 | MP0004145_abnormal_muscle_electrophysio | 0.84932511 |
127 | MP0009764_decreased_sensitivity_to | 0.83728440 |
128 | MP0003866_abnormal_defecation | 0.81560913 |
129 | MP0005645_abnormal_hypothalamus_physiol | 0.80694183 |
130 | MP0003195_calcinosis | 0.78471181 |
131 | MP0001299_abnormal_eye_distance/ | 0.78112000 |
132 | MP0000462_abnormal_digestive_system | 0.77775917 |
133 | MP0004147_increased_porphyrin_level | 0.76948176 |
134 | MP0000383_abnormal_hair_follicle | 0.76910236 |
135 | MP0002069_abnormal_eating/drinking_beha | 0.76350808 |
136 | MP0004858_abnormal_nervous_system | 0.76226436 |
137 | MP0001188_hyperpigmentation | 0.75019333 |
138 | MP0002090_abnormal_vision | 0.72786542 |
139 | MP0000747_muscle_weakness | 0.71863910 |
140 | MP0005535_abnormal_body_temperature | 0.69330907 |
141 | MP0003879_abnormal_hair_cell | 0.67888326 |
142 | MP0003938_abnormal_ear_development | 0.66070431 |
143 | MP0004085_abnormal_heartbeat | 0.65675599 |
144 | MP0001346_abnormal_lacrimal_gland | 0.65510154 |
145 | MP0001664_abnormal_digestion | 0.64315255 |
146 | MP0005195_abnormal_posterior_eye | 0.64261437 |
147 | MP0000013_abnormal_adipose_tissue | 0.63094895 |
148 | MP0000026_abnormal_inner_ear | 0.61213608 |
149 | MP0004185_abnormal_adipocyte_glucose | 0.60986844 |
150 | MP0004134_abnormal_chest_morphology | 0.59868662 |
151 | MP0000631_abnormal_neuroendocrine_gland | 0.57364250 |
152 | MP0003137_abnormal_impulse_conducting | 0.56192938 |
153 | MP0002909_abnormal_adrenal_gland | 0.56040541 |
154 | MP0000003_abnormal_adipose_tissue | 0.55474045 |
155 | MP0003787_abnormal_imprinting | 0.54954564 |
156 | MP0005451_abnormal_body_composition | 0.54657647 |
157 | MP0008260_abnormal_autophagy | 0.51791360 |
158 | MP0002295_abnormal_pulmonary_circulatio | 0.51633983 |
159 | MP0008872_abnormal_physiological_respon | 0.50006914 |
160 | MP0001661_extended_life_span | 0.49299450 |
161 | MP0003861_abnormal_nervous_system | 0.49153751 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Neurofibrillary tangles (HP:0002185) | 6.08627696 |
2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.78817313 |
3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.78817313 |
4 | Myokymia (HP:0002411) | 5.48292505 |
5 | Focal motor seizures (HP:0011153) | 5.09381418 |
6 | Cerebral inclusion bodies (HP:0100314) | 4.94801323 |
7 | Abnormality of the corticospinal tract (HP:0002492) | 4.76521205 |
8 | Back pain (HP:0003418) | 4.45226333 |
9 | Supranuclear gaze palsy (HP:0000605) | 4.33008314 |
10 | Sensory axonal neuropathy (HP:0003390) | 4.13278172 |
11 | Eczematoid dermatitis (HP:0000976) | 4.06385759 |
12 | Retrobulbar optic neuritis (HP:0100654) | 3.88831032 |
13 | Optic neuritis (HP:0100653) | 3.88831032 |
14 | Dysmetria (HP:0001310) | 3.85102841 |
15 | Spastic gait (HP:0002064) | 3.83699000 |
16 | Orchitis (HP:0100796) | 3.76555503 |
17 | Intention tremor (HP:0002080) | 3.73707130 |
18 | Focal seizures (HP:0007359) | 3.71025410 |
19 | Recurrent bacterial skin infections (HP:0005406) | 3.66911176 |
20 | Peripheral hypomyelination (HP:0007182) | 3.57699123 |
21 | Insidious onset (HP:0003587) | 3.55797690 |
22 | Termporal pattern (HP:0011008) | 3.55797690 |
23 | Myositis (HP:0100614) | 3.55761800 |
24 | Recurrent abscess formation (HP:0002722) | 3.54393472 |
25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.52957897 |
26 | Parakeratosis (HP:0001036) | 3.46862245 |
27 | Atonic seizures (HP:0010819) | 3.33552640 |
28 | Epileptic encephalopathy (HP:0200134) | 3.31596859 |
29 | Ankle clonus (HP:0011448) | 3.30280097 |
30 | Scanning speech (HP:0002168) | 3.25226209 |
31 | Abnormality of macrophages (HP:0004311) | 3.12325922 |
32 | Onion bulb formation (HP:0003383) | 3.11995495 |
33 | Action tremor (HP:0002345) | 2.98373286 |
34 | Akinesia (HP:0002304) | 2.98193536 |
35 | Retinal dysplasia (HP:0007973) | 2.92438044 |
36 | Papilledema (HP:0001085) | 2.89140223 |
37 | Broad-based gait (HP:0002136) | 2.84865600 |
38 | Hyperventilation (HP:0002883) | 2.83808607 |
39 | Abnormality of the labia minora (HP:0012880) | 2.74472765 |
40 | Thickened helices (HP:0000391) | 2.72924161 |
41 | Dialeptic seizures (HP:0011146) | 2.71297894 |
42 | Stomatitis (HP:0010280) | 2.71224838 |
43 | Lower limb muscle weakness (HP:0007340) | 2.71184050 |
44 | Keratoconjunctivitis sicca (HP:0001097) | 2.68516665 |
45 | Gaze-evoked nystagmus (HP:0000640) | 2.66076477 |
46 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.65947013 |
47 | Hemiplegia (HP:0002301) | 2.65679424 |
48 | Dysdiadochokinesis (HP:0002075) | 2.58246678 |
49 | Megalencephaly (HP:0001355) | 2.54213239 |
50 | Absence seizures (HP:0002121) | 2.53538676 |
51 | Visual hallucinations (HP:0002367) | 2.52666165 |
52 | Mediastinal lymphadenopathy (HP:0100721) | 2.52293167 |
53 | Cerebral hemorrhage (HP:0001342) | 2.49571289 |
54 | Abnormality of cochlea (HP:0000375) | 2.49051094 |
55 | Urinary urgency (HP:0000012) | 2.47651890 |
56 | Pheochromocytoma (HP:0002666) | 2.47327943 |
57 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.47120880 |
58 | Keratoconjunctivitis (HP:0001096) | 2.47054361 |
59 | Ventricular fibrillation (HP:0001663) | 2.45386478 |
60 | Generalized tonic-clonic seizures (HP:0002069) | 2.45155599 |
61 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.43540621 |
62 | Gingivitis (HP:0000230) | 2.43135999 |
63 | Alacrima (HP:0000522) | 2.40716110 |
64 | Clumsiness (HP:0002312) | 2.39998242 |
65 | Abnormal auditory evoked potentials (HP:0006958) | 2.39781389 |
66 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.38874938 |
67 | Generalized myoclonic seizures (HP:0002123) | 2.33850862 |
68 | Cerebral hypomyelination (HP:0006808) | 2.33820047 |
69 | Progressive cerebellar ataxia (HP:0002073) | 2.31812238 |
70 | Anxiety (HP:0000739) | 2.31748454 |
71 | Spontaneous hematomas (HP:0007420) | 2.29139914 |
72 | Increased circulating renin level (HP:0000848) | 2.29002952 |
73 | Obstructive sleep apnea (HP:0002870) | 2.28209152 |
74 | Gastrointestinal infarctions (HP:0005244) | 2.26946940 |
75 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.25525709 |
76 | Episodic fever (HP:0001954) | 2.25117703 |
77 | Amyloidosis (HP:0011034) | 2.23026368 |
78 | Spastic tetraparesis (HP:0001285) | 2.19572888 |
79 | Slow saccadic eye movements (HP:0000514) | 2.19088696 |
80 | Neuroendocrine neoplasm (HP:0100634) | 2.18258735 |
81 | Bowel incontinence (HP:0002607) | 2.17579540 |
82 | Memory impairment (HP:0002354) | 2.17337867 |
83 | Recurrent skin infections (HP:0001581) | 2.16167540 |
84 | Progressive inability to walk (HP:0002505) | 2.15455754 |
85 | Status epilepticus (HP:0002133) | 2.14362392 |
86 | Curly hair (HP:0002212) | 2.12953296 |
87 | Clonus (HP:0002169) | 2.12177373 |
88 | Papillary thyroid carcinoma (HP:0002895) | 2.10632832 |
89 | Mutism (HP:0002300) | 2.09778887 |
90 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.08253136 |
91 | Aplasia of the phalanges of the hand (HP:0009802) | 2.08253136 |
92 | Aplasia involving bones of the extremities (HP:0009825) | 2.08253136 |
93 | Abnormality of the endocardium (HP:0004306) | 2.07986774 |
94 | Neuronal loss in central nervous system (HP:0002529) | 2.07932358 |
95 | Truncal ataxia (HP:0002078) | 2.07788938 |
96 | Menstrual irregularities (HP:0000858) | 2.06665930 |
97 | Abnormal eating behavior (HP:0100738) | 2.06413883 |
98 | Pulmonary embolism (HP:0002204) | 2.06278591 |
99 | Excessive salivation (HP:0003781) | 2.06099978 |
100 | Drooling (HP:0002307) | 2.06099978 |
101 | Hypoplastic labia majora (HP:0000059) | 2.03954557 |
102 | Hemoptysis (HP:0002105) | 2.03742589 |
103 | Meningitis (HP:0001287) | 2.02199298 |
104 | Recurrent fungal infections (HP:0002841) | 2.02134190 |
105 | Abnormal large intestine physiology (HP:0012700) | 2.02034007 |
106 | Leukodystrophy (HP:0002415) | 2.01305976 |
107 | Postural instability (HP:0002172) | 2.01007008 |
108 | T lymphocytopenia (HP:0005403) | 1.99791043 |
109 | Spastic paraparesis (HP:0002313) | 1.99766305 |
110 | Torticollis (HP:0000473) | 1.98471953 |
111 | Febrile seizures (HP:0002373) | 1.97823691 |
112 | Poor eye contact (HP:0000817) | 1.97136926 |
113 | Morphological abnormality of the inner ear (HP:0011390) | 1.96879585 |
114 | Widely spaced teeth (HP:0000687) | 1.95485138 |
115 | Type II lissencephaly (HP:0007260) | 1.95238171 |
116 | Anteriorly placed anus (HP:0001545) | 1.94640861 |
117 | Abnormality of binocular vision (HP:0011514) | 1.93550397 |
118 | Diplopia (HP:0000651) | 1.93550397 |
119 | Aneurysm (HP:0002617) | 1.92504853 |
120 | Abnormality of glycolysis (HP:0004366) | 1.92378527 |
121 | Increased serum pyruvate (HP:0003542) | 1.92378527 |
122 | Autoamputation (HP:0001218) | 1.90979955 |
123 | Depression (HP:0000716) | 1.89750619 |
124 | Absent speech (HP:0001344) | 1.89404068 |
125 | Birth length less than 3rd percentile (HP:0003561) | 1.89338702 |
126 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.88893419 |
127 | Hemiparesis (HP:0001269) | 1.88048540 |
128 | Abnormality of the periventricular white matter (HP:0002518) | 1.87624203 |
129 | Metabolic alkalosis (HP:0200114) | 1.87595894 |
130 | Abnormality of glycolipid metabolism (HP:0010969) | 1.87154345 |
131 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.87154345 |
132 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.87154345 |
133 | Resting tremor (HP:0002322) | 1.86924012 |
134 | Hammertoe (HP:0001765) | 1.86228026 |
135 | Abnormality of the labia majora (HP:0012881) | 1.85924285 |
136 | Amblyopia (HP:0000646) | 1.85839214 |
137 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.84409732 |
138 | Bradykinesia (HP:0002067) | 1.84391375 |
139 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.83805072 |
140 | Decreased lacrimation (HP:0000633) | 1.83584868 |
141 | Pulmonary infiltrates (HP:0002113) | 1.83234243 |
142 | Abnormality of T cell number (HP:0011839) | 1.83020391 |
143 | Vasculitis (HP:0002633) | 1.80910529 |
144 | Blue irides (HP:0000635) | 1.80842007 |
145 | Arterial thrombosis (HP:0004420) | 1.80029374 |
146 | Apathy (HP:0000741) | 1.79786490 |
147 | Focal dystonia (HP:0004373) | 1.79625402 |
148 | Partial agenesis of the corpus callosum (HP:0001338) | 1.78690360 |
149 | Gingival bleeding (HP:0000225) | 1.78194486 |
150 | Urinary incontinence (HP:0000020) | 1.77649619 |
151 | Delusions (HP:0000746) | 1.77541451 |
152 | Cystic liver disease (HP:0006706) | 1.77494727 |
153 | Impaired social interactions (HP:0000735) | 1.77242879 |
154 | Abnormal social behavior (HP:0012433) | 1.77242879 |
155 | Obstructive lung disease (HP:0006536) | 1.77118318 |
156 | Chronic obstructive pulmonary disease (HP:0006510) | 1.77118318 |
157 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.77062880 |
158 | Abnormality of saccadic eye movements (HP:0000570) | 1.76630139 |
159 | Poor speech (HP:0002465) | 1.76194755 |
160 | Epileptiform EEG discharges (HP:0011182) | 1.74176052 |
Rank | Gene Set | Z-score |
---|---|---|
1 | STK39 | 4.57922519 |
2 | EPHA4 | 4.27515552 |
3 | OXSR1 | 3.67081671 |
4 | SGK2 | 2.49049411 |
5 | NTRK3 | 2.43361123 |
6 | TNIK | 2.37228217 |
7 | MAP3K9 | 2.27725754 |
8 | CDK19 | 2.20659904 |
9 | SGK3 | 2.10904355 |
10 | BCR | 2.05581372 |
11 | PRPF4B | 2.04717022 |
12 | NTRK1 | 2.04500056 |
13 | EPHB1 | 2.04084472 |
14 | PNCK | 2.03041450 |
15 | MARK1 | 1.98565861 |
16 | PAK6 | 1.93506386 |
17 | MAP3K13 | 1.92661493 |
18 | KSR2 | 1.83087444 |
19 | PKN1 | 1.71307057 |
20 | FGFR2 | 1.71091425 |
21 | BLK | 1.71076511 |
22 | AKT3 | 1.67808585 |
23 | WNK4 | 1.66168268 |
24 | UHMK1 | 1.57527546 |
25 | ARAF | 1.55118453 |
26 | CASK | 1.52556982 |
27 | FGR | 1.51883211 |
28 | MET | 1.49475731 |
29 | RIPK4 | 1.46643513 |
30 | CAMK2B | 1.45451105 |
31 | WNK1 | 1.43891906 |
32 | MAPKAPK5 | 1.42537814 |
33 | MAP3K4 | 1.42257629 |
34 | CSK | 1.42172234 |
35 | CDK5 | 1.39468935 |
36 | NEK6 | 1.39405684 |
37 | MINK1 | 1.37782053 |
38 | JAK2 | 1.36646661 |
39 | IRAK4 | 1.35965294 |
40 | DAPK2 | 1.35212623 |
41 | TYRO3 | 1.29142334 |
42 | MAP3K14 | 1.21133122 |
43 | JAK1 | 1.20376892 |
44 | ICK | 1.19809437 |
45 | CAMKK2 | 1.15797527 |
46 | MAP2K3 | 1.15588385 |
47 | PRKD3 | 1.13860763 |
48 | NTRK2 | 1.13020685 |
49 | CSNK1G2 | 1.13010011 |
50 | ROCK2 | 1.12072362 |
51 | CSNK1G3 | 1.10832647 |
52 | FES | 1.10492927 |
53 | TYK2 | 1.09707134 |
54 | SGK494 | 1.08382625 |
55 | SGK223 | 1.08382625 |
56 | CAMK2A | 1.07314033 |
57 | PBK | 1.06609662 |
58 | CSF1R | 1.06469834 |
59 | MAP2K7 | 1.05000054 |
60 | CSNK1A1L | 1.04708182 |
61 | MAP3K6 | 1.03619736 |
62 | CAMK2D | 1.03390500 |
63 | BMPR2 | 1.02938961 |
64 | MAP4K1 | 1.01221393 |
65 | STK38 | 0.98304854 |
66 | CDK14 | 0.96557115 |
67 | KSR1 | 0.96096597 |
68 | PAK3 | 0.94501313 |
69 | MARK2 | 0.94199593 |
70 | PTK2B | 0.94094581 |
71 | IKBKE | 0.94039281 |
72 | MAP3K11 | 0.92503780 |
73 | HCK | 0.92030403 |
74 | CLK1 | 0.90949483 |
75 | PLK2 | 0.88762283 |
76 | TNK2 | 0.88358193 |
77 | MAP3K2 | 0.88051193 |
78 | CDK15 | 0.87647754 |
79 | LIMK1 | 0.87232267 |
80 | SYK | 0.85068581 |
81 | CDK18 | 0.84900933 |
82 | ZAP70 | 0.84149301 |
83 | MAPK13 | 0.81545939 |
84 | STK11 | 0.80372415 |
85 | CSNK1G1 | 0.79821809 |
86 | PDPK1 | 0.79771246 |
87 | TAOK3 | 0.78870265 |
88 | PRKCQ | 0.77664471 |
89 | CDK11A | 0.76927049 |
90 | CAMK2G | 0.76096778 |
91 | GRK6 | 0.73217178 |
92 | MATK | 0.73074287 |
93 | GRK5 | 0.72424924 |
94 | FGFR3 | 0.68765313 |
95 | MAP2K4 | 0.67817047 |
96 | RAF1 | 0.67282729 |
97 | FYN | 0.65959866 |
98 | STK38L | 0.65578340 |
99 | RIPK1 | 0.64924981 |
100 | JAK3 | 0.64343318 |
101 | PRKCH | 0.64231414 |
102 | MAP3K5 | 0.63492152 |
103 | PRKCE | 0.63257228 |
104 | MAP3K12 | 0.62066528 |
105 | PRKCG | 0.61837853 |
106 | PHKG2 | 0.61628681 |
107 | PHKG1 | 0.61628681 |
108 | LYN | 0.61444456 |
109 | BRAF | 0.61442659 |
110 | CAMK1G | 0.60878212 |
111 | STK24 | 0.60066301 |
112 | ALK | 0.59633301 |
113 | PDK1 | 0.57915385 |
114 | YES1 | 0.57294182 |
115 | TXK | 0.55969091 |
116 | CAMKK1 | 0.55641271 |
117 | CAMK1D | 0.55019401 |
118 | LATS2 | 0.54200989 |
119 | SGK1 | 0.53195967 |
120 | MAPK12 | 0.53058302 |
121 | BTK | 0.53042112 |
122 | CAMK4 | 0.51022596 |
123 | MAP2K6 | 0.50979644 |
124 | TAOK1 | 0.50356059 |
125 | RET | 0.49996505 |
126 | IRAK1 | 0.49832954 |
127 | PRKD1 | 0.48518038 |
128 | DYRK1A | 0.47843769 |
129 | PDGFRB | 0.45347075 |
130 | CAMK1 | 0.45012116 |
131 | MAP3K3 | 0.44863306 |
132 | ERN1 | 0.42579811 |
133 | MOS | 0.42315823 |
134 | DMPK | 0.41020370 |
135 | NME1 | 0.40116429 |
136 | IRAK2 | 0.39962995 |
137 | MAPK10 | 0.39598419 |
138 | DYRK2 | 0.39553292 |
139 | TGFBR2 | 0.39149573 |
140 | CSNK1A1 | 0.37457543 |
141 | MUSK | 0.37317005 |
142 | CSNK1D | 0.36624275 |
143 | PRKG1 | 0.36448195 |
144 | PINK1 | 0.36205464 |
145 | PRKCZ | 0.33420515 |
146 | MAP3K1 | 0.33162751 |
147 | PRKACB | 0.32528970 |
148 | ERBB4 | 0.32513770 |
149 | RPS6KA3 | 0.30968164 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.95125593 |
2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.61208639 |
3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.53536110 |
4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.39093203 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.36883207 |
6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.23825479 |
7 | Morphine addiction_Homo sapiens_hsa05032 | 2.22775351 |
8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.20241181 |
9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.15165718 |
10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.10959723 |
11 | Long-term potentiation_Homo sapiens_hsa04720 | 1.99688218 |
12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.97354533 |
13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.94380411 |
14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86825044 |
15 | Salivary secretion_Homo sapiens_hsa04970 | 1.82261043 |
16 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.81535800 |
17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.81356428 |
18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.79898491 |
19 | Axon guidance_Homo sapiens_hsa04360 | 1.76311565 |
20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.75772414 |
21 | Long-term depression_Homo sapiens_hsa04730 | 1.75477917 |
22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.73158200 |
23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60108844 |
24 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.59633157 |
25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.54622160 |
26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.53741427 |
27 | Tuberculosis_Homo sapiens_hsa05152 | 1.51893117 |
28 | Renin secretion_Homo sapiens_hsa04924 | 1.48122666 |
29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.47904384 |
30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.41406890 |
31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40519984 |
32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.36669915 |
33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.35642003 |
34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.32597435 |
35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28667973 |
36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.28187952 |
37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.23813875 |
38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.23040673 |
39 | Taste transduction_Homo sapiens_hsa04742 | 1.18844932 |
40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16998337 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16166400 |
42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16000444 |
43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12637948 |
44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.12517398 |
45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.12401184 |
46 | Gap junction_Homo sapiens_hsa04540 | 1.10733501 |
47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.10710842 |
48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10683842 |
49 | Insulin secretion_Homo sapiens_hsa04911 | 1.10519715 |
50 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08846311 |
51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.08789074 |
52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.05298146 |
53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04538710 |
54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03689421 |
55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.03575674 |
56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.03070535 |
57 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00958166 |
58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00465351 |
59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99465908 |
60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99396278 |
61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99272480 |
62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98983836 |
63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.98902214 |
64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98730189 |
65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98717352 |
66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.97733403 |
67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.97267459 |
68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.96505214 |
69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.96401129 |
70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.91720216 |
71 | Protein export_Homo sapiens_hsa03060 | 0.90969622 |
72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89626885 |
73 | Legionellosis_Homo sapiens_hsa05134 | 0.89590266 |
74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89262235 |
75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.89171752 |
76 | Phagosome_Homo sapiens_hsa04145 | 0.88740853 |
77 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.88037049 |
78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.86232534 |
79 | Salmonella infection_Homo sapiens_hsa05132 | 0.84116441 |
80 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84091560 |
81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83622193 |
82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83536455 |
83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83081982 |
84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.82872416 |
85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82688333 |
86 | Malaria_Homo sapiens_hsa05144 | 0.82097303 |
87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81907002 |
88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81097184 |
89 | Platelet activation_Homo sapiens_hsa04611 | 0.80644504 |
90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79223776 |
91 | Phototransduction_Homo sapiens_hsa04744 | 0.78996086 |
92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78241782 |
93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77550960 |
94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77307763 |
95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77288229 |
96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.76352911 |
97 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74283632 |
98 | Influenza A_Homo sapiens_hsa05164 | 0.74117495 |
99 | Melanogenesis_Homo sapiens_hsa04916 | 0.73871078 |
100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72990288 |
101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72745944 |
102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72082629 |
103 | Pertussis_Homo sapiens_hsa05133 | 0.71556239 |
104 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71253177 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.70067586 |
106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68894684 |
107 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66819387 |
108 | Measles_Homo sapiens_hsa05162 | 0.66533991 |
109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66323758 |
110 | Tight junction_Homo sapiens_hsa04530 | 0.65211369 |
111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64572694 |
112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64159111 |
113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63051984 |
114 | Glioma_Homo sapiens_hsa05214 | 0.62350469 |
115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61936850 |
116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61493869 |
117 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60832467 |
118 | Hepatitis B_Homo sapiens_hsa05161 | 0.60213154 |
119 | Hepatitis C_Homo sapiens_hsa05160 | 0.59998457 |
120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59132072 |
121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58409877 |
122 | Amoebiasis_Homo sapiens_hsa05146 | 0.57695535 |
123 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56066961 |
124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55949687 |
125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52529694 |
126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51175648 |
127 | Prion diseases_Homo sapiens_hsa05020 | 0.50213933 |
128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49777316 |
129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48816637 |
130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46992969 |
131 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.45913700 |
132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45761718 |
133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44995587 |
134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44116056 |
135 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43933277 |
136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42925538 |
137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42765025 |
138 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40577675 |
139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38043354 |
140 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37212492 |
141 | Bile secretion_Homo sapiens_hsa04976 | 0.36842463 |
142 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35623773 |
143 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34827325 |
144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34824520 |
145 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34502836 |
146 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34437769 |
147 | Alcoholism_Homo sapiens_hsa05034 | 0.34127526 |